Loading
Life sciences · Journal article
Angewandte Chemie · October 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Cuproptosis represents a promising strategy for cancer therapy, yet its clinical translation is hampered by unexpected deactivation and off‐target toxicity of copper ions during their delivery to tumors. We developed a copper metal‐organic framework‐based nanoplatform (CuF) with H 2 O 2 responsiveness and Raman self‐tracking capability for cuproptosis‐mediated antitumor therapy. CuF was prepared by coordinating Cu 2+ with an alkyne‐bearing ligand, followed by PEGylation and incorporation of an iron‐based catalyst. CuF undergoes catalyst‐mediated oxidative cleavage of alkynyl bonds under tumor‐associated elevated H 2 O 2 levels, causing CuF degradation and Cu 2+ release. Released Cu 2+ causes copper overload in tumor cells, thereby inducing potent cuproptosis. Meanwhile, the resultant aldehydes and acids generated by the oxidative cleavage of alkynes can further synergistically potentiate cuproptosis. Consequently, CuF demonstrated high antitumor efficacy in a 4T1 tumor‐bearing mouse model (with a tumor inhibition rate of 91%). Moreover, alkynes in the metal‐organic framework (MOF) backbone provided an intrinsically enhanced Raman signal, enabling label‐free self‐tracking of CuF distribution and degradation in cells and tissue sections through Raman imaging. Overall, this work not only provides a new paradigm for cuproptosis‐based anticancer agents, but also offers a versatile strategy for engineering H 2 O 2 responsive materials and Raman imaging nanoplatforms.